Opiant Pharmaceuticals to Report Fourth Quarter 2019 Financial Results and Host Conference Call and Webcast on Wednesday, March 4

SANTA MONICA, Calif., Feb. 24, 2020 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (?Opiant?) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, today announced that it will report its financial results for the fourth quarter and year ended December 31, 2019, after the market close, and will host a corporate update conference call and webcast on Wednesday, March 4, at 4:30 p.m. Eastern Time.